Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Verslaving 2/2015

01-07-2015 | Middelen

Ecstasy: PMMA, MDMA en hooggedoseerde pillen

Auteurs: Dr. Raymond J.M. Niesink, Dr. Tibor M. Brunt, MD Dr. Esther A. Croes

Gepubliceerd in: Verslaving | Uitgave 2/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Extract

Terneergeslagen zitten ze in de familiekamer van de intensive care. Zojuist is hun vriend overleden aan de gevolgen van een overdosering ecstasy. ‘Ik begrijp het niet, hoe kan dit nou?’, vraagt de vriendin van de overledene zich vertwijfeld af. ‘We zouden met z’n vijven voor één keertje stevig gaan dansen. We hebben alle voorzorgsmaatregelen genomen. We hebben ons goed ingelezen over de risico’s. We wisten wat we slikten. We hebben alle adviezen opgevolgd.’ De arts: ‘Het is een misverstand om te denken dat je alle risico’s van ecstasy kunt voorkomen. Regelmatig zien we op onze afdeling spoedeisende hulp jongeren die worden binnengebracht met een ernstige intoxicatie na het slikken van ecstasy. In de meeste gevallen loopt het goed af, maar een enkele keer overlijdt de patiënt. Gebruik van ecstasy brengt risico’s met zich mee. Wil je geen risico lopen, dan moet je niet gebruiken.’ …
Literatuur
go back to reference Brunt, T. M., Koeter, M. W., Niesink, R. J., & Brink, W. van den (2012). Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 220, 751–762. PubMedCrossRef Brunt, T. M., Koeter, M. W., Niesink, R. J., & Brink, W. van den (2012). Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 220, 751–762. PubMedCrossRef
go back to reference Croes, E. A., Vogels, N., Pol, P. van der (2014). Factsheet Monitor drugsincidenten 2013. Utrecht: Trimbos-instituut. Croes, E. A., Vogels, N., Pol, P. van der (2014). Factsheet Monitor drugsincidenten 2013. Utrecht: Trimbos-instituut.
go back to reference Dumont, G. J., Sweep, F. C., Steen, R. van der, Hermsen, R., Donders, A. R., Touw, D. J., Gerven, J. M. van, Buitelaar, J. K., Verkes, R. J. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Society for Neuroscience, 4, 359–366. CrossRef Dumont, G. J., Sweep, F. C., Steen, R. van der, Hermsen, R., Donders, A. R., Touw, D. J., Gerven, J. M. van, Buitelaar, J. K., Verkes, R. J. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Society for Neuroscience, 4, 359–366. CrossRef
go back to reference Goossens, F. X., Frijns, T., Hasselt, N. E. van, & Laar, M. W. van (2014). Het grote uitgaansonderzoek 2013. Uitgaanspatronen, middelengebruik en risicogedrag onder uitgaande jongeren en jongvolwassenen. Utrecht: Trimbos-instituut. Goossens, F. X., Frijns, T., Hasselt, N. E. van, & Laar, M. W. van (2014). Het grote uitgaansonderzoek 2013. Uitgaanspatronen, middelengebruik en risicogedrag onder uitgaande jongeren en jongvolwassenen. Utrecht: Trimbos-instituut.
go back to reference Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21, 53–63. PubMedCrossRef Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21, 53–63. PubMedCrossRef
go back to reference Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003). The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Pharmacological Reviews, 55, 463–508. PubMedCrossRef Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003). The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Pharmacological Reviews, 55, 463–508. PubMedCrossRef
go back to reference Gudelsky, G. A., & Yamamoto, B. K. (2003). Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods in Molecular Medicine, 79, 55-73. Gudelsky, G. A., & Yamamoto, B. K. (2003). Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods in Molecular Medicine, 79, 55-73.
go back to reference Henry, J. A., Jeffreys, K. J., & Dawling, S. (1992). Toxicity and deaths from 3, 4-methylenedioxymethamphetamine (‘ecstasy’). Lancet, 340, 384–387. PubMedCrossRef Henry, J. A., Jeffreys, K. J., & Dawling, S. (1992). Toxicity and deaths from 3, 4-methylenedioxymethamphetamine (‘ecstasy’). Lancet, 340, 384–387. PubMedCrossRef
go back to reference Irvine, R. J., Keane, M., Felgate, P., McCann, U. D., Callaghan, P. D., & White, J. M. (2006). Plasma drug concentrations and physiological measures in ‘dance party’ participants. Neuropsychopharmacology, 31, 424–430. PubMedCrossRef Irvine, R. J., Keane, M., Felgate, P., McCann, U. D., Callaghan, P. D., & White, J. M. (2006). Plasma drug concentrations and physiological measures in ‘dance party’ participants. Neuropsychopharmacology, 31, 424–430. PubMedCrossRef
go back to reference Kalant, H. (2001). The pharmacology and toxicology of ‘ecstasy’(MDMA) and related drugs. Canadian Medical Association Journal, 165, 917–928. PubMedCentralPubMed Kalant, H. (2001). The pharmacology and toxicology of ‘ecstasy’(MDMA) and related drugs. Canadian Medical Association Journal, 165, 917–928. PubMedCentralPubMed
go back to reference Kiyatkin, E. A., & Sharma, H. S. (2012). Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse. International Review of Neurobiology, 102, 147. Kiyatkin, E. A., & Sharma, H. S. (2012). Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse. International Review of Neurobiology, 102, 147.
go back to reference Krul, J. (2013). Mass Gathering Medicine at raves: Incidents and substance-related emergencies. Amsterdam: Vrije Universiteit PhD thesis. Krul, J. (2013). Mass Gathering Medicine at raves: Incidents and substance-related emergencies. Amsterdam: Vrije Universiteit PhD thesis.
go back to reference Krul, J., Girbes, A. R., & Sanou, B. T. (2012). Increase in serious ecstasy-related incidents in the Netherlands. Lancet, 380, 1385. PubMedCrossRef Krul, J., Girbes, A. R., & Sanou, B. T. (2012). Increase in serious ecstasy-related incidents in the Netherlands. Lancet, 380, 1385. PubMedCrossRef
go back to reference Nicol, J. J., Yarema, M. C., Jones, G. R., Martz, W., Purssell, R. A., MacDonald, J. C., & Buxton, J. A. (2015). Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: A case series. Canadian Medical Association Open Access Journal, 3, E83–E90. Nicol, J. J., Yarema, M. C., Jones, G. R., Martz, W., Purssell, R. A., MacDonald, J. C., & Buxton, J. A. (2015). Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: A case series. Canadian Medical Association Open Access Journal, 3, E83–E90.
go back to reference Ovaska, H., Viljoen, A., Puchnarewicz, M., Button, J., Ramsey, J., Holt, D. W., & Wood, D. M. (2008). First case report of recreational use of 2, 5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. European Journal of Emergency Medicine, 15, 354–356. PubMedCrossRef Ovaska, H., Viljoen, A., Puchnarewicz, M., Button, J., Ramsey, J., Holt, D. W., & Wood, D. M. (2008). First case report of recreational use of 2, 5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. European Journal of Emergency Medicine, 15, 354–356. PubMedCrossRef
go back to reference Parrott, A. C. (2012). MDMA and temperature: A review of the thermal effects of ‘Ecstasy’in humans. Drug and Alcohol Dependence, 121, 1–9. PubMedCrossRef Parrott, A. C. (2012). MDMA and temperature: A review of the thermal effects of ‘Ecstasy’in humans. Drug and Alcohol Dependence, 121, 1–9. PubMedCrossRef
go back to reference Patel, M. M., Belson, M. G., Longwater, A. B., Olson, K. R., & Miller, M. A. (2005). Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. Journal of Emergency Medicine, 29, 451–454. PubMedCrossRef Patel, M. M., Belson, M. G., Longwater, A. B., Olson, K. R., & Miller, M. A. (2005). Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. Journal of Emergency Medicine, 29, 451–454. PubMedCrossRef
go back to reference Poel, A. van der, Doekhie, J., Verdurmen, J., Wouters, M., Korf, D., & Laar, M. van (2010). Feestmeter 2008–2009: uitgaan en middelengebruik onder bezoekers van party’s en clubs. Utrecht: Bonger Instituut voor Criminologie UvA en Trimbos-instituut. Poel, A. van der, Doekhie, J., Verdurmen, J., Wouters, M., Korf, D., & Laar, M. van (2010). Feestmeter 2008–2009: uitgaan en middelengebruik onder bezoekers van party’s en clubs. Utrecht: Bonger Instituut voor Criminologie UvA en Trimbos-instituut.
go back to reference Rietjens, S. J., Hondebrink, L., Westerink, R. H., & Meulenbelt, J. (2012). Pharmacokinetics and pharmacodynamics of 3, 4-methylenedioxymethamphetamine (MDMA): Interindividual differences due to polymorphisms and drug-drug interactions. Critical Reviews in Toxicology, 42, 854–876. PubMedCrossRef Rietjens, S. J., Hondebrink, L., Westerink, R. H., & Meulenbelt, J. (2012). Pharmacokinetics and pharmacodynamics of 3, 4-methylenedioxymethamphetamine (MDMA): Interindividual differences due to polymorphisms and drug-drug interactions. Critical Reviews in Toxicology, 42, 854–876. PubMedCrossRef
go back to reference Rooij, A. van, Schoenmakers, T. M., & Van de Mheen, D. (2011). Nationaal prevalentie onderzoek middelengebruik 2009: de kerncijfers. Rotterdam: IVO. Rooij, A. van, Schoenmakers, T. M., & Van de Mheen, D. (2011). Nationaal prevalentie onderzoek middelengebruik 2009: de kerncijfers. Rotterdam: IVO.
go back to reference Sample, I. (2015). ‘Superman’ pill deaths spark calls for dangerous-drugs alert system. Guardian, 16 Januari. Sample, I. (2015). ‘Superman’ pill deaths spark calls for dangerous-drugs alert system. Guardian, 16 Januari.
go back to reference Saunders, N., & Doblin, R. (1996). Ecstasy: Dance, trance & transformation. Oakland: Quick American Archives. Saunders, N., & Doblin, R. (1996). Ecstasy: Dance, trance & transformation. Oakland: Quick American Archives.
go back to reference Schifano, F., Corkery, J., Naidoo, V., Oyefeso, A., & Ghodse, H. (2010). Overview of amphetamine-type stimulant mortality data-UK, 1997–2007. Neuropsychobiology, 61, 122. PubMedCrossRef Schifano, F., Corkery, J., Naidoo, V., Oyefeso, A., & Ghodse, H. (2010). Overview of amphetamine-type stimulant mortality data-UK, 1997–2007. Neuropsychobiology, 61, 122. PubMedCrossRef
go back to reference Strobbe, L., Jager, C. P. de, Louwerse, E. S., Rozendaal, F. W. (2007). [Fatal ecstasy intoxication in a 22-year-old man]. Nederlands Tijdschrift voor Geneeskunde, 151, 1690–1694. PubMed Strobbe, L., Jager, C. P. de, Louwerse, E. S., Rozendaal, F. W. (2007). [Fatal ecstasy intoxication in a 22-year-old man]. Nederlands Tijdschrift voor Geneeskunde, 151, 1690–1694. PubMed
go back to reference Tancer, M. E., & Johanson, C. E. (2001). The subjective effects of MDMA and mCPP in moderate MDMA users. Drug and Alcohol Dependence, 65, 97–101. PubMedCrossRef Tancer, M. E., & Johanson, C. E. (2001). The subjective effects of MDMA and mCPP in moderate MDMA users. Drug and Alcohol Dependence, 65, 97–101. PubMedCrossRef
go back to reference Ter Bogt, T. F. T., Gabhainn, S. N., Simons-Morton, B. G., Ferreira, M., Hublet, A., Godeau, E. E., & Richter, M. (2012). Dance is the new metal: Adolescent music preferences and substance use across Europe. Substance Use and Misuse, 47, 130–142. PubMedCentralPubMedCrossRef Ter Bogt, T. F. T., Gabhainn, S. N., Simons-Morton, B. G., Ferreira, M., Hublet, A., Godeau, E. E., & Richter, M. (2012). Dance is the new metal: Adolescent music preferences and substance use across Europe. Substance Use and Misuse, 47, 130–142. PubMedCentralPubMedCrossRef
go back to reference The Guardian (2014). Clubbers warned of overdose risk from super-strength ecstasy. Guardian, 28 november. The Guardian (2014). Clubbers warned of overdose risk from super-strength ecstasy. Guardian, 28 november.
go back to reference Torre, R. De La, Farre, M., Ortuno, J., Mas, M., Brenneisen, R., Roset, P. N., & Cami, J. (2000). Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. British Journal of Clinical Pharmacology, 49, 104–109. PubMedCentralPubMedCrossRef Torre, R. De La, Farre, M., Ortuno, J., Mas, M., Brenneisen, R., Roset, P. N., & Cami, J. (2000). Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. British Journal of Clinical Pharmacology, 49, 104–109. PubMedCentralPubMedCrossRef
go back to reference Torre, R. De La, Farre, M., Roset, P. N., López, C. H., Mas, M., Ortuno, J., & Cami, J. (2000). Pharmacology of MDMA in humans. Annals of the New York Academy of Sciences, 914, 225–237. PubMedCrossRef Torre, R. De La, Farre, M., Roset, P. N., López, C. H., Mas, M., Ortuno, J., & Cami, J. (2000). Pharmacology of MDMA in humans. Annals of the New York Academy of Sciences, 914, 225–237. PubMedCrossRef
go back to reference Traub, S. J., Hoffman, R. S., & Nelson, L. S. (2002). The ‘Ecstasy’ hangover: Hyponatremia due to 3, 4-methylenedioxymethamphetamine. Journal of Urban Health, 79, 549–555. PubMedCentralPubMedCrossRef Traub, S. J., Hoffman, R. S., & Nelson, L. S. (2002). The ‘Ecstasy’ hangover: Hyponatremia due to 3, 4-methylenedioxymethamphetamine. Journal of Urban Health, 79, 549–555. PubMedCentralPubMedCrossRef
go back to reference Vervaeke, H. (2008). Stimulerende middelen: xtc. In H. Vervaeke (red.), Drugs en alcohol; gebruik, misbruik en verslaving (pp. 245–278). Houten: Bohn Stafleu van Loghum. CrossRef Vervaeke, H. (2008). Stimulerende middelen: xtc. In H. Vervaeke (red.), Drugs en alcohol; gebruik, misbruik en verslaving (pp. 245–278). Houten: Bohn Stafleu van Loghum. CrossRef
go back to reference Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA (‘ecstasy’) in MDMA-naive healthy volunteers. Neuropsychopharmacology, 19, 241–251. PubMedCrossRef Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA (‘ecstasy’) in MDMA-naive healthy volunteers. Neuropsychopharmacology, 19, 241–251. PubMedCrossRef
go back to reference Wouters, M., Nabben, T., Benschop, A., & Korf, D. J. (2014). Drug use trends in Amsterdam nightlife, 2013. Jellinekreeks, 25. Amsterdam: Rozenberg Publishers. Wouters, M., Nabben, T., Benschop, A., & Korf, D. J. (2014). Drug use trends in Amsterdam nightlife, 2013. Jellinekreeks, 25. Amsterdam: Rozenberg Publishers.
Metagegevens
Titel
Ecstasy: PMMA, MDMA en hooggedoseerde pillen
Auteurs
Dr. Raymond J.M. Niesink
Dr. Tibor M. Brunt
MD Dr. Esther A. Croes
Publicatiedatum
01-07-2015
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Verslaving / Uitgave 2/2015
Print ISSN: 1574-1842
Elektronisch ISSN: 1875-7073
DOI
https://doi.org/10.1007/s12501-015-0020-3